drugset / Trial / NCT01038752
Evaluation of Non-cytotoxic Suramin as a Chemosensitizer in Non-small Cell Lung Cancer
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to evaluate the benefit of adding suramin at a non-cytotoxic dose to carboplatin and docetaxel regimen in the treatment of chemo-naïve patients with non-small cell lung cancer.
Timeline
- Start
- 2010-08
- Primary completion
- 2012-11
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | suramin | Small molecule | — | — |
| Background | Carboplatin | Small molecule | — | — |
| Background | Docetaxel | Small molecule | 56 mg/m2 | — |
| Background | Docetaxel | Small molecule | 75 mg/m2 | — |